SCHEMBL439630

SCHEMBL439630

CC(C)C1NC(=O)COC1=O

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CACNA1G O43497 1/20 0.32
HDAC4 P56524 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL439631 1.00 CACNA1G (0.32) CACNA1GHDAC4HDAC1HDAC2HDAC6
SCHEMBL3232578 0.81 KDM4E (0.38) CACNA1G
SCHEMBL3232586 0.81 KDM4E (0.38) CACNA1G
SCHEMBL24462432 0.80 PPIA (0.30)
SCHEMBL3230560 0.71
SCHEMBL3228079 0.71 GAA (0.36)
SCHEMBL3228085 0.71 GAA (0.36)
SCHEMBL31692716 0.71 GAA (0.36)
SCHEMBL2071787 0.67 ABCB1 (0.32)
SCHEMBL4652277 0.67 ABCB1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8652723-B2 Toner particles comprising colorant-polyesters XEROX CORPORATION (US) 2014-02-18 US claimed
US-8343715-B2 Photochromic polyesters and methods of producing photochromic polyesters XEROX CORPORATION (US) 2013-01-01 US claimed
US-20120231386-A1 TONER PARTICLES COMPRISING COLORANT-POLYESTERS XEROX CORPORATION (US) 2012-09-13 US claimed
US-20120108775-A1 PHOTOCHROMIC POLYESTERS AND METHODS OF PRODUCING PHOTOCHROMIC POLYESTERS XEROX CORPORATION (US) 2012-05-03 US claimed
US-20120065359-A1 COLORANT-POLYESTERS AND METHODS OF PRODUCING COLORANT-POLYESTERS XEROX CORPORATION (US) 2012-03-15 US claimed
US-8652723-B2 Toner particles comprising colorant-polyesters XEROX CORPORATION (US) 2014-02-18 US disclosed
US-8349970-B2 Phase change composition for printing XEROX CORPORATION (US) 2013-01-08 US disclosed
US-8343715-B2 Photochromic polyesters and methods of producing photochromic polyesters XEROX CORPORATION (US) 2013-01-01 US disclosed
US-20120231386-A1 TONER PARTICLES COMPRISING COLORANT-POLYESTERS XEROX CORPORATION (US) 2012-09-13 US disclosed
US-20120128881-A1 PHASE CHANGE COMPOSITION FOR PRINTING XEROX CORPORATION (US) 2012-05-24 US disclosed
US-20120108775-A1 PHOTOCHROMIC POLYESTERS AND METHODS OF PRODUCING PHOTOCHROMIC POLYESTERS XEROX CORPORATION (US) 2012-05-03 US disclosed
US-20120065359-A1 COLORANT-POLYESTERS AND METHODS OF PRODUCING COLORANT-POLYESTERS XEROX CORPORATION (US) 2012-03-15 US disclosed
EP-2024418-B1 MULTIBLOCK COPOLYMERS WITH SHAPE-MEMORY PROPERTIES GEESTHACHT GKSS FORSCHUNG (DE) 2010-11-17 EP disclosed
US-20100062036-A1 Multiblock Copolymers with Shape-Memory Properties GKSS-FORSCHUNGSZENTRUM GEESTHACHT GMBH (DE) 2010-03-11 US disclosed
EP-2024418-A1 MULTIBLOCK COPOLYMERS WITH SHAPE-MEMORY PROPERTIES GKSS-FORSCHUNGSZENTRUM GEESTHACHT GMBH (DE) 2009-02-18 EP disclosed
WO-2007131893-A1 MULTIBLOCK COPOLYMERS WITH SHAPE-MEMORY PROPERTIES GKSS- FORSCHUNGSZENTRUM GEESTHACHT GMBH (DE) 2007-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100062036-A1 Multiblock Copolymers with Shape-Memory Properties PUF60, DDOST, PCBP1 CACNA1G 942/4885HDAC4 2414/4885HDAC1 3665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.